보험처방과 실제 임상처방의 분석을 통한 한약제제 적응증 비교 고찰 - 보중익기탕을 중심으로 -
The comparison and consideration of indications of herbal medicine through analysis about insured herbal extracts and clinical prescriptions - Focusing on Bojungikgi-tang -
0
조회
0
다운로드
14
인용
0
참고문헌
키워드
초록
Objectives : The discussion of enlargement of Korean Medical insurance has been existed since 1987. But it had less effects. For better discussion, we compared insured herbal extracts and clinical prescriptions. Methods : The database of insured herbal extracts and clinical prescriptions bas set up to compare the ratios of herbal weight and analyze indications of insured herbal extracts and diagnosis and chief complain of clinical prescriptions. Results & Conclusions : The most frequent insured herbal extract is Bojungiki-tang. Analysis about indications of insured herbal extracts and diagnosis and chief complain of clinical prescriptions is that Bojungiki-tang is used frequently for gastrointestinal diseases, pulmonary diseases, and not for diseases. Bojungikgi-tang is also used for muscloskeletal dieases, hemorrhage, and ischemia.
Abstract
Objectives : The discussion of enlargement of Korean Medical insurance has been existed since 1987. But it had less effects. For better discussion, we compared insured herbal extracts and clinical prescriptions. Methods : The database of insured herbal extracts and clinical prescriptions bas set up to compare the ratios of herbal weight and analyze indications of insured herbal extracts and diagnosis and chief complain of clinical prescriptions. Results & Conclusions : The most frequent insured herbal extract is Bojungiki-tang. Analysis about indications of insured herbal extracts and diagnosis and chief complain of clinical prescriptions is that Bojungiki-tang is used frequently for gastrointestinal diseases, pulmonary diseases, and not for diseases. Bojungikgi-tang is also used for muscloskeletal dieases, hemorrhage, and ischemia.
참고문헌 (7)
- 대한한방병원협회, "한방의료급여기준", ~ (2008)
- 서부일, "한방의료보험 제도의 개선방안에 관한 연구", 동서의학, 20(3), pp.3~20 (1995)
- 한약제제 재평가 도입방안 연구, "권동렬", 식품의약품안전청, 16~ (2004)
- 김윤경, "한약제제 보험급여 주상병과 처방분석", 대한본초학회지, 21(4), pp.1~10 (2006), 대한본초학회
- 손지형, "한의사의 복합과립제 사용 실태 조사 및 복합과립제 건강보험 급여 시행방안에 대한 연구", 대한한의학회지, 30(4), pp.64~78 (2009), 대한한의학회
- 건강보험심사평가원, "다빈도 상명 비교(외래)2009,2010", ~
- 권용찬, "한방건강보험 약제 투약 실태 및 활성화 방안 연구", 대한본초학회지, 27(2), pp.1~16 (2012), 대한본초학회